CARL ZEISS MEDITEC AG - BR (AFX.DE) Stock Price, Forecast & Analysis

Europe • Frankfurt Stock Exchange • FRA:AFX • DE0005313704

27.04 EUR
-0.3 (-1.1%)
Last: Feb 6, 2026, 01:32 PM

AFX.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap2.42B
Revenue(TTM)2.23B
Net Income(TTM)141.22M
Shares89.44M
Float34.64M
52 Week High71.65
52 Week Low27.1
Yearly Dividend0.6
Dividend Yield1.96%
EPS(TTM)1.61
PE16.8
Fwd PE13.96
Earnings (Next)02-10
IPO2000-03-20
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
AFX.DE short term performance overview.The bars show the price performance of AFX.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

AFX.DE long term performance overview.The bars show the price performance of AFX.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of AFX.DE is 27.04 EUR. In the past month the price decreased by -34.4%. In the past year, price decreased by -51.95%.

CARL ZEISS MEDITEC AG - BR / AFX Daily stock chart

AFX.DE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AFX.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to AFX.DE. Both the profitability and the financial health of AFX.DE get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AFX.DE Financial Highlights

Over the last trailing twelve months AFX.DE reported a non-GAAP Earnings per Share(EPS) of 1.61. The EPS decreased by -19.9% compared to the year before.


Industry RankSector Rank
PM (TTM) 6.34%
ROA 4.15%
ROE 6.67%
Debt/Equity 0.27
Chartmill High Growth Momentum
EPS Q2Q%-14.49%
Sales Q2Q%8.27%
EPS 1Y (TTM)-19.9%
Revenue 1Y (TTM)7.82%

AFX.DE Forecast & Estimates

22 analysts have analysed AFX.DE and the average price target is 49.78 EUR. This implies a price increase of 84.08% is expected in the next year compared to the current price of 27.04.

For the next year, analysts expect an EPS growth of 20.35% and a revenue growth 4.23% for AFX.DE


Analysts
Analysts71.82
Price Target49.78 (84.1%)
EPS Next Y20.35%
Revenue Next Year4.23%

AFX.DE Ownership

Ownership
Inst Owners25.21%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

AFX.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
2M6 MEDTRONIC PLC16.87113.317B
1MDT MEDTRONIC PLC16.13108.304B
SHL SIEMENS HEALTHINEERS AG17.2948.053B
1PHIA KONINKLIJKE PHILIPS NV16.2723.842B
PHIA KONINKLIJKE PHILIPS NV16.1323.669B
PHI1 KONINKLIJKE PHILIPS NV15.8823.264B
BIM BIOMERIEUX19.2311.54B
DIA DIASORIN SPA18.124.173B
OBCK OTTOBOCK SE & CO KGAA19.613.916B
1AFX CARL ZEISS MEDITEC AG - BR14.52.513B

About AFX.DE

Company Profile

AFX logo image Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.

Company Info

CARL ZEISS MEDITEC AG - BR

Goeschwitzer Strasse 51-52

Jena THUERINGEN DE

Employees: 5730

AFX Company Website

AFX Investor Relations

Phone: 493641220331

CARL ZEISS MEDITEC AG - BR / AFX.DE FAQ

What does AFX do?

Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.


What is the stock price of CARL ZEISS MEDITEC AG - BR today?

The current stock price of AFX.DE is 27.04 EUR. The price decreased by -1.1% in the last trading session.


What is the dividend status of CARL ZEISS MEDITEC AG - BR?

CARL ZEISS MEDITEC AG - BR (AFX.DE) has a dividend yield of 1.96%. The yearly dividend amount is currently 0.6.


What is the ChartMill rating of CARL ZEISS MEDITEC AG - BR stock?

AFX.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Would investing in CARL ZEISS MEDITEC AG - BR be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AFX.DE.


What is CARL ZEISS MEDITEC AG - BR worth?

CARL ZEISS MEDITEC AG - BR (AFX.DE) has a market capitalization of 2.42B EUR. This makes AFX.DE a Mid Cap stock.